Foresee's Oral ALDH2 Activator_ Mirivadelgat to Enter Clinical Testing in Parkinson's Disease in the SLEIPNIR ... (original) (raw)

TAIPEI, June 8, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that...read full story